Oslo, Norway, 8 February 2022
Vistin Pharma ASA will release its fourth quarter 2021 results on Thursday 17th of February 2022. Vistin Pharma will host a conference call for all shareholders and interested parties on Thursday 17th of February at 08:30 CET. There will be a Q&A session following the management discussion.
The conference call will be held in English.
The fourth quarter conference call will be available via web and audio through the following access points:
Telephone conference:
Confirmation Code:…….. 7590346
International dial-In:…….. +44 (0) 2071 928338
Norway, Oslo:……………. +47 21563015
United States, New York: +1 6467413167
Webcast:
https://edge.media-server.com/mmc/p/jb9o62eq
*****
For further information, please contact:
Alexander Karlsen
CFO
+47 97053621
alexander.karlsen@vistin.com
— HUTCHMED continues to deliver on its strategy outlined in November 2022 to create value, prioritize…
Provides financial flexibility by reducing near-term debt maturities, deferring principal redemption payment, and reducing near-term…
Innovative Solutions Transform Treatment for Burn Victims, Chronic Wounds, and Scar ReductionCHICAGO, Dec. 31, 2024…
TEL AVIV, Israel, Dec. 31, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or…
HOUSTON--(BUSINESS WIRE)--Hamershlag Private Capital Management Limited (HPCM), a leading health technology investment firm, has announced…
HOUSTON--(BUSINESS WIRE)--Hamershlag Private Capital Management Limited (HPCM), a leading health technology investment firm, has announced…